News from modis therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 19, 2019, 08:00 ET Modis Therapeutics Announces that MT1621 Receives Breakthrough Therapy Designation from FDA for the Treatment of TK2 Deficiency

Modis Therapeutics announced today that the FDA has granted Breakthrough Therapy designation to MT1621, Modis' investigational treatment for patients ...


Nov 13, 2018, 08:00 ET Modis Therapeutics Announces PRIME Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency

Modis Therapeutics announced today that the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) designation to MT1621, Modis'...


Oct 29, 2018, 08:00 ET Modis Therapeutics Announces Appointment of Matthew R. Patterson to Board of Directors

Modis Therapeutics announced today that Matthew R. Patterson, co-founder and Chief Executive Officer of Audentes Therapeutics, has joined Modis'...